# Otis Worldwide Corp: financial statements, quarterly

OTIS · NYSE · CIK 1781335 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/otis.md) · [Financials](/companies/otis/financials.md) · [Filings](/companies/otis/filings.md) · [Insiders](/companies/otis/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/otis/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,620 d](/filings/0001781335-26-000011.md) | [3,437](/filings/0001781335-25-000021.md) | [3,601](/filings/0001781335-25-000038.md) | [3,548](/filings/0001781335-25-000049.md) | [3,675 d](/filings/0001781335-26-000011.md) | [3,350](/filings/0001781335-26-000075.md) | [3,595](/filings/0001781335-26-000113.md) | [3,690](/filings/0001781335-26-000127.md) | [3,796 d](/filings/0001781335-26-000011.md) | [3,566](/filings/0001781335-26-000075.md) | [3,859](/filings/0001781335-26-000113.md) | [3,914](/filings/0001781335-26-000127.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [37.0 d](/filings/0001781335-26-000011.md) | [36.0](/filings/0001781335-25-000021.md) | [39.0](/filings/0001781335-25-000038.md) | [40.0](/filings/0001781335-25-000049.md) | [37.0 d](/filings/0001781335-26-000011.md) | [37.0](/filings/0001781335-26-000075.md) | [38.0](/filings/0001781335-26-000113.md) | [36.0](/filings/0001781335-26-000127.md) | [41.0 d](/filings/0001781335-26-000011.md) | [38.0](/filings/0001781335-26-000075.md) | [39.0](/filings/0001781335-26-000113.md) | [40.0](/filings/0001781335-26-000127.md) |
| Selling, general and administrative | $m | [498 d](/filings/0001781335-26-000011.md) | [462](/filings/0001781335-25-000021.md) | [449](/filings/0001781335-25-000038.md) | [455](/filings/0001781335-25-000049.md) | [495 d](/filings/0001781335-26-000011.md) | [464](/filings/0001781335-26-000075.md) | [499](/filings/0001781335-26-000113.md) | [504](/filings/0001781335-26-000127.md) | [512 d](/filings/0001781335-26-000011.md) | [510](/filings/0001781335-26-000075.md) | [520](/filings/0001781335-26-000113.md) | [489](/filings/0001781335-26-000127.md) |
| Operating income | $m | [522 d](/filings/0001781335-26-000011.md) | [544](/filings/0001781335-25-000021.md) | [570](/filings/0001781335-25-000038.md) | [363](/filings/0001781335-25-000049.md) | [531 d](/filings/0001781335-26-000011.md) | [411](/filings/0001781335-26-000075.md) | [547](/filings/0001781335-26-000113.md) | [586](/filings/0001781335-26-000127.md) | [589 d](/filings/0001781335-26-000011.md) | [539](/filings/0001781335-26-000075.md) | [575](/filings/0001781335-26-000113.md) | [620](/filings/0001781335-26-000127.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [133 d](/filings/0001781335-26-000011.md) | [126](/filings/0001781335-25-000021.md) | [94.0](/filings/0001781335-25-000038.md) | [(45.0)](/filings/0001781335-25-000049.md) | [130 d](/filings/0001781335-26-000011.md) | [110](/filings/0001781335-26-000075.md) | [98.0](/filings/0001781335-26-000113.md) | [129](/filings/0001781335-26-000127.md) | [142 d](/filings/0001781335-26-000011.md) | [127](/filings/0001781335-26-000075.md) | [98.0](/filings/0001781335-26-000113.md) | [126](/filings/0001781335-26-000127.md) |
| Net income | $m | [323 d](/filings/0001781335-26-000011.md) | [353](/filings/0001781335-25-000021.md) | [415](/filings/0001781335-25-000038.md) | [540](/filings/0001781335-25-000049.md) | [337 d](/filings/0001781335-26-000011.md) | [243](/filings/0001781335-26-000075.md) | [393](/filings/0001781335-26-000113.md) | [374](/filings/0001781335-26-000127.md) | [374 d](/filings/0001781335-26-000011.md) | [340](/filings/0001781335-26-000075.md) | [428](/filings/0001781335-26-000113.md) | [414](/filings/0001781335-26-000127.md) |
| Diluted EPS | $ per share | not reported | [0.86](/filings/0001781335-25-000021.md) | [1.02](/filings/0001781335-25-000038.md) | [1.34](/filings/0001781335-25-000049.md) | not reported | [0.61](/filings/0001781335-26-000075.md) | [0.99](/filings/0001781335-26-000113.md) | [0.95](/filings/0001781335-26-000127.md) | not reported | [0.87](/filings/0001781335-26-000075.md) | [1.12](/filings/0001781335-26-000113.md) | [1.08](/filings/0001781335-26-000127.md) |
| Basic EPS | $ per share | not reported | [0.87](/filings/0001781335-25-000021.md) | [1.03](/filings/0001781335-25-000038.md) | [1.35](/filings/0001781335-25-000049.md) | not reported | [0.61](/filings/0001781335-26-000075.md) | [1.00](/filings/0001781335-26-000113.md) | [0.96](/filings/0001781335-26-000127.md) | not reported | [0.88](/filings/0001781335-26-000075.md) | [1.12](/filings/0001781335-26-000113.md) | [1.09](/filings/0001781335-26-000127.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | period not labelled (2025-10-31) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.9](/filings/0001781335-25-000021.md) | [0.9](/filings/0001781335-25-000038.md) | [0.8](/filings/0001781335-25-000049.md) | [2.3](/filings/0001781335-26-000011.md) | [1.9](/filings/0001781335-26-000075.md) | [0.7](/filings/0001781335-26-000113.md) | [0.8](/filings/0001781335-26-000127.md) | [0.1](/filings/0001781335-26-000011.md) | [1.1](/filings/0001781335-26-000127.md) | [0.8](/filings/0001781335-26-000075.md) | [0.8](/filings/0001781335-26-000113.md) | [0.9](/filings/0001781335-26-000127.md) |
| Current assets | $bn | [6.1](/filings/0001781335-24-000022.md) | [6.2](/filings/0001781335-24-000039.md) | [6.5](/filings/0001781335-24-000057.md) | [7.7](/filings/0001781335-26-000011.md) | [7.4](/filings/0001781335-25-000021.md) | [6.4](/filings/0001781335-25-000038.md) | [6.6](/filings/0001781335-25-000049.md) | not reported | [6.5](/filings/0001781335-26-000127.md) | [6.5](/filings/0001781335-26-000075.md) | [6.8](/filings/0001781335-26-000113.md) | [6.9](/filings/0001781335-26-000127.md) |
| Total assets | $bn | [9.8](/filings/0001781335-24-000022.md) | [9.9](/filings/0001781335-24-000039.md) | [10.3](/filings/0001781335-24-000057.md) | [11.3](/filings/0001781335-26-000011.md) | [11.2](/filings/0001781335-25-000021.md) | [10.5](/filings/0001781335-25-000038.md) | [10.8](/filings/0001781335-25-000049.md) | not reported | [10.7](/filings/0001781335-26-000127.md) | [10.5](/filings/0001781335-26-000075.md) | [11.2](/filings/0001781335-26-000113.md) | [11.3](/filings/0001781335-26-000127.md) |
| Current liabilities | $bn | [6.3](/filings/0001781335-24-000022.md) | [7.9](/filings/0001781335-24-000039.md) | [8.1](/filings/0001781335-24-000057.md) | [7.7](/filings/0001781335-26-000011.md) | [7.9](/filings/0001781335-25-000021.md) | [7.2](/filings/0001781335-25-000038.md) | [7.1](/filings/0001781335-25-000049.md) | not reported | [7.7](/filings/0001781335-26-000127.md) | [7.7](/filings/0001781335-26-000075.md) | [8.2](/filings/0001781335-26-000113.md) | [8.1](/filings/0001781335-26-000127.md) |
| Total liabilities | $bn | [14.6](/filings/0001781335-24-000022.md) | [14.7](/filings/0001781335-24-000039.md) | [15.0](/filings/0001781335-24-000057.md) | [16.0](/filings/0001781335-26-000011.md) | [16.2](/filings/0001781335-25-000021.md) | [15.7](/filings/0001781335-25-000038.md) | [16.1](/filings/0001781335-25-000049.md) | not reported | [15.9](/filings/0001781335-26-000127.md) | [16.0](/filings/0001781335-26-000075.md) | [16.6](/filings/0001781335-26-000113.md) | [16.5](/filings/0001781335-26-000127.md) |
| Long-term debt | $bn | [6.8](/filings/0001781335-24-000022.md) | [5.5](/filings/0001781335-24-000039.md) | [5.6](/filings/0001781335-24-000057.md) | [7.0](/filings/0001781335-26-000011.md) | [6.9](/filings/0001781335-25-000021.md) | [7.1](/filings/0001781335-25-000038.md) | [7.6](/filings/0001781335-25-000049.md) | not reported | [6.9](/filings/0001781335-26-000127.md) | [6.9](/filings/0001781335-26-000075.md) | [7.0](/filings/0001781335-26-000113.md) | [7.1](/filings/0001781335-26-000127.md) |
| Current portion of debt | $bn | [0.0](/filings/0001781335-24-000022.md) | [1.3](/filings/0001781335-24-000039.md) | [1.3](/filings/0001781335-24-000057.md) | [1.3](/filings/0001781335-26-000011.md) | [1.4](/filings/0001781335-25-000021.md) | [0.1](/filings/0001781335-25-000038.md) | [0.1](/filings/0001781335-25-000049.md) | not reported | [0.8](/filings/0001781335-26-000127.md) | [0.7](/filings/0001781335-26-000075.md) | [1.2](/filings/0001781335-26-000113.md) | [1.2](/filings/0001781335-26-000127.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001781335-24-000022.md) | [0.4](/filings/0001781335-24-000039.md) | [0.4](/filings/0001781335-24-000057.md) | [0.1](/filings/0001781335-26-000011.md) | [0.0](/filings/0001781335-25-000021.md) | [0.5](/filings/0001781335-25-000038.md) | [0.3](/filings/0001781335-25-000049.md) | [0.1](/filings/0001781335-26-000011.md) | [0.2](/filings/0001781335-26-000127.md) | [0.2](/filings/0001781335-26-000075.md) | [0.2](/filings/0001781335-26-000113.md) | [0.0](/filings/0001781335-26-000127.md) |
| Shareholders' equity | $bn | [(5.0)](/filings/0001781335-24-000022.md) | [(5.0)](/filings/0001781335-24-000039.md) | [(4.9)](/filings/0001781335-24-000057.md) | [(4.8)](/filings/0001781335-26-000011.md) | [(5.1)](/filings/0001781335-25-000021.md) | [(5.4)](/filings/0001781335-25-000038.md) | [(5.4)](/filings/0001781335-25-000049.md) | not reported | [(5.4)](/filings/0001781335-26-000127.md) | [(5.7)](/filings/0001781335-26-000075.md) | [(5.7)](/filings/0001781335-26-000113.md) | [(5.4)](/filings/0001781335-26-000127.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [597 d](/filings/0001781335-26-000011.md) | [171](/filings/0001781335-25-000021.md) | [308 d](/filings/0001781335-25-000038.md) | [394 d](/filings/0001781335-25-000049.md) | [690 d](/filings/0001781335-26-000011.md) | [190](/filings/0001781335-26-000075.md) | [215 d](/filings/0001781335-26-000113.md) | [374 d](/filings/0001781335-26-000127.md) | [817 d](/filings/0001781335-26-000011.md) | [413](/filings/0001781335-26-000075.md) | [267 d](/filings/0001781335-26-000113.md) | [337 d](/filings/0001781335-26-000127.md) |
| Capital expenditure | $m | [42.0 d](/filings/0001781335-26-000011.md) | [31.0](/filings/0001781335-25-000021.md) | [24.0 d](/filings/0001781335-25-000038.md) | [32.0 d](/filings/0001781335-25-000049.md) | [39.0 d](/filings/0001781335-26-000011.md) | [34.0](/filings/0001781335-26-000075.md) | [36.0 d](/filings/0001781335-26-000113.md) | [37.0 d](/filings/0001781335-26-000127.md) | [45.0 d](/filings/0001781335-26-000011.md) | [33.0](/filings/0001781335-26-000075.md) | [44.0 d](/filings/0001781335-26-000113.md) | [39.0 d](/filings/0001781335-26-000127.md) |
| Dividends paid | $m | [139 d](/filings/0001781335-26-000011.md) | [138](/filings/0001781335-25-000021.md) | [157 d](/filings/0001781335-25-000038.md) | [155 d](/filings/0001781335-25-000049.md) | [156 d](/filings/0001781335-26-000011.md) | [155](/filings/0001781335-26-000075.md) | [164 d](/filings/0001781335-26-000113.md) | [164 d](/filings/0001781335-26-000127.md) | [164 d](/filings/0001781335-26-000011.md) | [163](/filings/0001781335-26-000075.md) | [167 d](/filings/0001781335-26-000113.md) | [168 d](/filings/0001781335-26-000127.md) |
| Share repurchases | $m | [225 d](/filings/0001781335-26-000011.md) | [300](/filings/0001781335-25-000021.md) | [300 d](/filings/0001781335-25-000038.md) | [200 d](/filings/0001781335-25-000049.md) | [207 d](/filings/0001781335-26-000011.md) | [253](/filings/0001781335-26-000075.md) | [308 d](/filings/0001781335-26-000113.md) | [248 d](/filings/0001781335-26-000127.md) | [0.0 d](/filings/0001781335-26-000011.md) | [400](/filings/0001781335-26-000075.md) | [407 d](/filings/0001781335-26-000113.md) | [0.0 d](/filings/0001781335-26-000127.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [418](/filings/0001781335-24-000022.md) | [416](/filings/0001781335-24-000039.md) | [414](/filings/0001781335-24-000057.md) | [408](/filings/0001781335-25-000021.md) | [406](/filings/0001781335-25-000038.md) | [403](/filings/0001781335-25-000049.md) | [399](/filings/0001781335-26-000075.md) | [396](/filings/0001781335-26-000113.md) | [393](/filings/0001781335-26-000127.md) | [390](/filings/0001781335-26-000075.md) | [384](/filings/0001781335-26-000113.md) | [382](/filings/0001781335-26-000127.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 380,710,513 at 2026-10-15, from the cover of the [10-Q filed 2026-10-29](/filings/0001781335-26-000127.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:45 ET. No prices; not investment advice.